Greyson International Inc. to Hold Investor Conference Call on Thursday, November 21, 2013
19 November 2013 - 8:13PM
Business Wire
Greyson International, Inc. (OTC Pink Sheets: GYSN),
developer of an innovative patented topical delivery technology
targeting the multi-billion dollar cosmetics and OTC pharmaceutical
industries, today announced that it would be holding an investor
conference call on Thursday, November 21, 2013, at 4:15 pm EST. The
conference call dial in number is 530-881-1300 and the Participant
Access Code is 934487. The recorded version of the conference call
will be available for playback after the call is concluded. Dial
530-881-1399 to listen.
“Our company has laid the foundation and set into motion the
launch of Greyson Skincare, licensing deals and pharmaceutical
joint ventures. I’m looking forward to giving details on these
activities,” said Harvey Tauman, CEO of Greyson International Inc.
“In addition, I’m looking forward to discussing our future plans on
this call, as we bring our patented Trilexon trans-dermal delivery
system to market and ultimately unlock significant value for our
shareholders in 2014 and beyond.”
In preparation you may view the new videos on the Greyson
website.
Welcome (Company & Technology Overview)
Detailed explanation of Trilexon® technology (second video)
Live Financial Investor Presentation Oct. 2013
About Greyson International, Inc.
Greyson’s primary focus is on its recently patented Trilexon®
delivery system that’s taking the multi-billion dollar cosmetics
and OTC pharmaceuticals industries by storm. Based on this
technology, the company’s patented Trilexon® foundation creates a
fine surface that is insoluble in water, keeping it in place even
after sweating or contact with water. Ingredients are released
continuously over an extended period of time, ensuring that the
skin receives treatment at a constant steady pace to give it a
healthy and youthful look. In addition to cosmetic applications,
Trilexon® has benefits in the medical field where it is important
to deliver topical active ingredients. Trilexon® is a registered
trademark of Greyson International. The company also holds an
investment in Blake Oil and Gas Limited (“Blake”), a privately
owned, Guernsey registered, Oil and Gas Company. For more
information, visit our website; http://greysonintl.com and
join the Greyson International's Facebook
page http://www.facebook.com/GreysonInternationalInc.
This release contains information about management’s view of our
future expectations, plans and prospects that constitute
forward-looking statements for purposes of the safe harbor
provisions under The Private Securities Litigation Reform Act of
1995. Actual results may differ materially from historical results
or those indicated by these forward-looking statements as a result
of a variety of factors including, but not limited to, risks and
uncertainties associated with our financial condition, our ability
to sell our products and our ability to compete with competitors.
We encourage you to review other factors that may affect our future
results on any current or future documents we file periodically
with the Securities & Exchange Commission.
Greyson International Inc.Harvey Tauman, 954-482-0497Chief
Executive OfficerHarvey@greysonintl.com
Greyson (CE) (USOTC:GYSN)
Historical Stock Chart
Von Jan 2025 bis Feb 2025
Greyson (CE) (USOTC:GYSN)
Historical Stock Chart
Von Feb 2024 bis Feb 2025